Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bis-daunomycin hydrazones: interactions with DNA.

D R Phillips1, R T Brownlee, J A Reiss

  • 1Department of Biochemistry, La Trobe University, Bundoora, Victoria, Australia.

Investigational New Drugs
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How Well Do We Know the Neutron-Matter Equation of State at the Densities Inside Neutron Stars? A Bayesian Approach with Correlated Uncertainties.

Physical review letters·2020
Same author

Power counting of contact-range currents in effective field theory.

Physical review letters·2015
Same author

Measurement of Compton scattering from the deuteron and an improved extraction of the neutron electromagnetic polarizabilities.

Physical review letters·2015
Same author

Radioarsenic from a portable (72)Se/(72)As generator: a current perspective.

Current radiopharmaceuticals·2012
Same author

Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways.

Biochemical pharmacology·2012
Same author

Barminomycin, a model for the development of new anthracyclines.

Anti-cancer agents in medicinal chemistry·2009

New bis-daunomycin hydrazones bind DNA strongly, showing unique sequence preferences. These compounds bis-intercalate into DNA, offering potential for novel therapeutic applications.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • DNA Intercalation

Background:

  • Daunomycin is a known DNA-intercalating agent.
  • Developing novel DNA-binding agents is crucial for therapeutic advancements.

Purpose of the Study:

  • To synthesize and characterize novel bis-daunomycin hydrazones.
  • To investigate the DNA binding properties and sequence specificity of these compounds.

Main Methods:

  • Synthesis of bis-daunomycin hydrazones using diester diamide linkers.
  • DNA binding studies using DNA lengthening assays.
  • Dissociation kinetics under detergent sequestration.
  • Transcriptional footprinting for DNA sequence specificity analysis.

Main Results:

Related Experiment Videos

  • All synthesized bis-daunomycin hydrazones bis-intercalated into DNA.
  • Compounds showed significantly increased DNA binding affinity and slower dissociation compared to daunomycin.
  • Neighbor exclusion and occupation of 6 base pairs were observed.
  • A distinct DNA sequence preference, particularly for 5'-CACA sites, was identified.

Conclusions:

  • Bis-daunomycin hydrazones represent a promising class of DNA-binding agents.
  • Their enhanced DNA interaction and sequence specificity suggest potential as targeted therapeutics.
  • Further research into their biological activity and therapeutic potential is warranted.